Abstract
Innovative vaccines are required to fight human and animal diseases. Improved immunogenicity, safety, easy administration, and low cost are among the innovations that are pursued in this field. Nanogels are materials with attractive features to meet these requirements; they consist of solid, jelly like materials produced by crosslinking of synthetic or natural polymers (or a combination of both) with a high water-holding capacity. Herein, the state of the art of nanogels-based vaccines is provided. Synthesis and functionalization methods for nanogels are described. Thus far, several groups have evaluated nanogels as vaccine delivery vehicles leading to promising data for nanovaccines against cancer, obesity, and infectious diseases. The most advanced candidates are nanovaccines against cancer, based on cholesteryl pullulan nanogels, that have been evaluated in clinical trials revealing proper immunogenicity and safety. The key perspectives for this topic include expanding the assessment of mucosal vaccines and implementing green syntheses approaches, which could lead to lower production cost and enhanced safety.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akiyoshi K, Yamaguchi S, Sunamoto J (1991) Self-aggregates of hydrophobic polysaccharide derivatives. Chem Lett 20(7):1263–1266
Akiyoshi K, Deguchi S, Moriguchi N, Yamaguchi S, Sunamoto J (1993) Self-aggregates of hydrophobized polysaccharides in water. Formation and characteristics of nanoparticles. Macromolecules 26(12):3062–3068
Alshehri R, Ilyas AM, Hasan A, Arnaout A, Ahmed F, Memic A (2016) Carbon nanotubes in biomedical applications: factors, mechanisms, and remedies of toxicity. J Med Chem 59(18):8149–8167
Ayame H, Morimoto N, Akiyoshi K (2008) Self-assembled cationic nanogels for intracellular protein delivery. Bioconjug Chem 19(4):882–890
Azegami T, Yuki Y, Sawada S, Mejima M, Ishige K, Akiyoshi K, Itoh H, Kiyono H (2017) Nanogel-based nasal ghrelin vaccine prevents obesity. Mucosal Immunol 10:1351–1360
Cheng KC, Demirci A, Catchmark JM (2011) Pullulan: biosynthesis, production, and applications. Appl Microbiol Biotechnol 92(1):29
Chiu M, Bao C, Sadarangani M (2019) Dilemmas with rotavirus vaccine: the neonate and immunocompromised. Pediatr Infect Dis J 38.(6S Suppl 1:S43–S46
Feng JL, Qi JR, Yin SW, Wang JM, Guo J, Weng JY, Liu QR, Yang XQ (2015) Fabrication and characterization of stable soy β-conglycinin-dextran core-shell nanogels prepared via a self-assembly approach at the isoelectric point. J Agric Food Chem 63(26):6075–6083
Fukuyama Y, Yuki Y, Katakai Y, Harada N, Takahashi H, Takeda S, Mejima M, Joo S, Kurokawa S, Sawada S, Shibata H, Park EJ, Fujihashi K, Briles DE, Yasutomi Y, Tsukada H, Akiyoshi K, Kiyono H (2015) Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques. Mucosal Immunol 8:1144–1153
Gheibi-Hayat SM, Darroudi M (2019) Nanovaccine: a novel approach in immunization. J Cell Physiol 234(8):12530–12536
Gu XG, Schmitt M, Hiasa A, Nagata Y, Ikeda H, Sasaki Y, Akiyoshi K, Sunamoto J, Nakamura H, Kuribayashi K, Shiku H (1998) A novel hydrophobized polysaccharide/oncoprotein complex vaccine induces in vitro and in vivo cellular and humoral immune responses against HER2-expressing murine sarcomas. Cancer Res 58(15):3385–3390
Kabanov AV, Vinogradov SV (2009) Nanogels as pharmaceutical carriers: finite networks of infinite capabilities. Angew Chem Int Ed 48(30):5418–5429
Kageyama S, Kitano S, Hirayama M, Nagata Y, Imai H, Shiraishi T, Akiyoshi K, Scott AM, Murphy R, Hoffman EW, Old LJ, Katayama N, Shiku H (2008) Humoral immune responses in patients vaccinated with 1–146 HER2 protein complexed with cholesteryl pullulan nanogel. Cancer Sci 99:601–607
Kendre PN, Satav TS (2019) Current trends and concepts in the design and development of nanogel carrier systems. Polym Bull 76(3):1595–1617
Kitano S, Kageyama S, Nagata Y, Miyahara Y, Hiasa A, Naota H, Okumura S, Imai H, Shiraishi T, Masuya M, Nishikawa M, Sunamoto J, Akiyoshi K, Kanematsu T, Scott AM, Murphy R, Hoffman EW, Old LJ, Shiku H (2006) HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan. Clin Cancer Res 12:7397–7405
Kong IG, Sato A, Yuki Y, Nochi T, Takahashi H, Sawada S, Mejima M, Kurokawa S, Okada K, Sato S, Briles DE, Kunisawa J, Inoue Y, Yamamoto M, Akiyoshi K, Kiyono H (2013) Nanogel-based PspA intranasal vaccine prevents invasive disease and nasal colonization by Streptococcus pneumoniae. Infect Immun 81:1625–1634
Krauss S, Zhang CY, Lowell BB (2005) The mitochondrial uncoupling-protein homologues. Nat Rev Mol Cell Biol 6(3):248
Kumari M, Survase SA, Singhal RS (2008) Production of schizophyllan using Schizophyllum commune NRCM. Bioresour Technol 99(5):1036–1043
Kyogoku N, Ikeda H, Tsuchikawa T, Abiko T, Fujiwara A, Maki T, Yamamura Y, Ichinokawa M, Tanaka K, Imai N, Miyahara Y, Kageyama S, Shiku H, Hirano S (2016) Time-dependent transition of the immunoglobulin G subclass and immunoglobulin E response in cancer patients vaccinated with cholesteryl pullulan-melanoma antigen gene-A4 nanogel. Oncol Lett 12:4493–4504
Layton JB, Butler AM, Panozzo CA, Brookhart MA (2018) Rotavirus vaccination and short-term risk of adverse events in US infants. Paediatr Perinat Epidemiol 32(5):448–457
Li D, Kordalivand N, Fransen MF, Ossendorp F, Raemdonck K, Vermonden T, Hennink WE, Van Nostrum CF (2015) Reduction-sensitive dextran nanogels aimed for intracellular delivery of antigens. Adv Funct Mater 25(20):2993–3003
Li D, Sun F, Bourajjaj M, Chen Y, Pieters EH, Chen J, van den Dikkenberg JB, Lou B, Camps MG, Ossendorp F, Hennink WE, Vermonden T, van Nostrum CF (2016) Strong in vivo antitumor responses induced by an antigen immobilized in nanogels via reducible bonds. Nanoscale 8:19592–19604
Lopez-Chaves C, Soto-Alvaredo J, Montes-Bayon M, Bettmer J, Llopis J, Sanchez-Gonzalez C (2017) Gold nanoparticles: distribution, bioaccumulation and toxicity. In vitro and in vivo studies. Nanomedicine 14:1):1–1)12
Matyjaszewski K, Davis TP (2002) Handbook of radical polymerization. Wiley, Hoboken
Miquel-Clopés A, Bentley EG, Stewart JP, Carding SR (2019) Mucosal vaccines and technology. Clin Exp Immunol 196(2):205–214
Miyamoto N, Mochizuki S, Sakurai K (2014) Enhanced immunostimulation with crosslinked CpG-DNA/β-1, 3-glucan nanoparticle through hybridization. Chem Lett 43(7):991–993
Miyamoto N, Mochizuki S, Fujii S, Yoshida K, Sakurai K (2017) Adjuvant activity enhanced by cross-linked CpG-oligonucleotides in β-glucan nanogel and its antitumor effect. Bioconjug Chem 28:565–573
Moad G, Solomon DH (2006) The chemistry of radical polymerization. Elsevier, Amsterdam
Muraoka D, Harada N, Hayashi T, Tahara Y, Momose F, Sawada S, Mukai SA, Akiyoshi K, Shiku H (2014) Nanogel-based immunologically stealth vaccine targets macrophages in the medulla of lymph node and induces potent antitumor immunity. ACS Nano 8:9209–9218
Neamtu I, Rusu AG, Diaconu A, Nita LE, Chiriac AP (2017) Basic concepts and recent advances in nanogels as carriers for medical applications. Drug Deliv 24(1):539–557
Nochi T, Yuki Y, Takahashi H, Sawada S, Mejima M, Kohda T, Harada N, Kong IG, Sato A, Kataoka N, Tokuhara D, Kurokawa S, Takahashi Y, Tsukada H, Kozaki S, Akiyoshi K, Kiyono H (2010) Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. Nat Mater 9:572–578
Nuhn L, Vanparijs N, De Beuckelaer A, Lybaert L, Verstraete G, Deswarte K, Lienenklaus S, Shukla NM, Salyer AC, Lambrecht BN, Grooten J (2016) pH-degradable imidazoquinoline-ligated nanogels for lymph node-focused immune activation. Proc Natl Acad Sci 113(29):8098–8103
Nuhn L, Van Hoecke L, Deswarte K, Schepens B, Li Y, Lambrecht BN, De Koker S, David SA, Saelens X, De Geest BG (2018) Potent anti-viral vaccine adjuvant based on pH-degradable nanogels with covalently linked small molecule imidazoquinoline TLR7/8 agonist. Biomaterials 178:643–651
Patarroyo ME, Bermúdez A, Moreno-Vranich A (2012) Towards the development of a fully protective Plasmodium falciparum antimalarial vaccine. Expert Rev Vaccines 11(9):1057–1070
Purwada A, Tian YF, Huang W, Rohrbach KM, Deol S, August A, Singh A (2016) Self-assembly protein nanogels for safer Cancer immunotherapy. Adv Healthc Mater 5:1413–1419
Raemdonck K, Demeester J, De Smedt S (2009) Advanced nanogel engineering for drug delivery. Soft Matter 5(4):707–715
Rosales-Mendoza S, Salazar-González JA, Decker EL, Reski R (2016) Implications of plant glycans in the development of innovative vaccines. Expert Rev Vaccines 15(7):915–925
Ross AC, Chen Q, Ma Y (2011) Vitamin a and retinoic acid in the regulation of B-cell development and antibody production. Vitam Horm 86:103–126
Sanson N, Rieger J (2010) Synthesis of nanogels/microgels by conventional and controlled radical crosslinking copolymerization. Polym Chem 1(7):965–977
Soni KS, Desale SS, Bronich TK (2016) Nanogels: an overview of properties, biomedical applications and obstacles to clinical translation. J Control Release 240:109–126
Toyoda M, Hama S, Ikeda Y, Nagasaki Y, Kogure K (2015) Anti-cancer vaccination by transdermal delivery of antigen peptide-loaded nanogels via iontophoresis. Int J Pharm 483:110–114
Uthaman S, Maya S, Jayakumar R, Cho CS, Park IK (2014) Carbohydrate-based nanogels as drug and gene delivery systems. J Nanosci Nanotechnol 14(1):694–704
Verheyen E, Delain-Bioton L, van der Wal S, el Morabit N, Barendregt A, Hennink WE, van Nostrum CF (2010) Conjugation of methacrylamide groups to a model protein via a reducible linker for immobilization and subsequent triggered release from hydrogels. Macromol Biosci 10(12):1517–1526
Wang C, Li P, Liu L, Pan H, Li H, Cai L, Ma Y (2016) Self-adjuvanted nanovaccine for cancer immunotherapy: role of lysosomal rupture-induced ROS in MHC class I antigen presentation. Biomaterials 79:88–100
Yadav H, Al Halabi N, Alsalloum G (2017) Nanogels as novel drug delivery systems—a review. J Pharm Pharm Res 1(1):5
Zhang X, Malhotra S, Molina M, Haag R (2015) Micro- and nanogels with labile crosslinks – from synthesis to biomedical applications. Chem Soc Rev 44:1948–1973
Zhang MY, Guo J, Hu XM, Zhao SQ, Li SL, Wang J (2019) An in vivo anti-tumor effect of eckol from marine brown algae by improving the immune response. Food Funct 10:4361. https://doi.org/10.1039/c9fo00865a
Zhu G, Zhang F, Ni Q, Niu G, Chen X (2017) Efficient nanovaccine delivery in cancer immunotherapy. ACS Nano 11(3):2387–2392
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rosales-Mendoza, S., González-Ortega, O. (2019). Nanogels-Based Mucosal Vaccines. In: Nanovaccines. Springer, Cham. https://doi.org/10.1007/978-3-030-31668-6_6
Download citation
DOI: https://doi.org/10.1007/978-3-030-31668-6_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-31667-9
Online ISBN: 978-3-030-31668-6
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)